Tirzepatide

Description

Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By simultaneously activating both incretin pathways, Tirzepatide has become a major focus of scientific research investigating glucose metabolism, appetite regulation, energy balance, and body composition.

Researchers have studied Tirzepatide extensively in preclinical and clinical settings to better understand the physiological effects of dual incretin receptor activation. Ongoing research continues to examine its influence on insulin secretion, glucagon regulation, gastric emptying, satiety signalling, and metabolic function, making it an important tool in endocrinology and obesity research.

Areas of Scientific Interest

• Research has investigated Tirzepatide for its dual activation of GIP and GLP-1 receptors involved in metabolic regulation and glucose homeostasis.
• Clinical studies have examined its effects on appetite regulation, satiety signalling, gastric emptying, and body weight through incretin-mediated pathways.
• Experimental research has explored the role of dual incretin receptor agonists in insulin secretion, glucagon regulation, lipid metabolism, and energy balance.
• Ongoing investigations continue to evaluate combined GIP and GLP-1 signalling in obesity, metabolic disease, cardiovascular physiology, and endocrine research.

Product Features

• High-purity lyophilised peptide
• Contains 10mg Tirzepatide
• Manufactured for laboratory and scientific research
• Quality tested for identity and purity
• Securely packaged to help maintain product integrity

References

• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
• Frias JP, et al. Efficacy and Safety of Tirzepatide Monotherapy versus Semaglutide in Type 2 Diabetes. The Lancet.
• Coskun T, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes and obesity. Molecular Metabolism.